“…Table 1 summarizes the main characteristics of eligible studies. These studies were published from 2006 to 2018 and conducted in China [6,12,13], Turkey [7,9], Israel [10], Japan [8], and Mexico [11]. The sample size of each study ranged from 62 to 8750, with a total of 21667 ACS patients.…”